What We're Reading: Page 115
Industry reads hand-picked by our editors
Jan 03, 2023
-
The Wall Street Journal
Drug Prices Reach New High — in the Millions
-
Financial Times
GSK on hunt for attractive biotechs ‘hiding in plain sight’
-
The New York Times
An Architect of Biden’s Antitrust Push Is Leaving the White House
-
Wired
A Drug to Treat Aging May Not Be a Pipe Dream
Dec 22, 2022
-
Science
Scientists tie third clinical trial death to experimental Alzheimer’s drug
-
The Wall Street Journal
Many Hospitals Get Big Drug Discounts. That Doesn’t Mean Markdowns for Patients.
-
Evaluate Vantage
Biotech tries everything it can in Nash
-
Nature
After AlphaFold: protein-folding contest seeks next big breakthrough
Dec 21, 2022
-
The Wall Street Journal
Two Biotech CEOs Indicted on Securities Fraud Charges
-
Nature
Twitter changed science — what happens now it’s in turmoil?
-
San Francisco Business Times
Peanut allergy drug developer Aimmune to cut 75 jobs as parent Nestlé looks to sell lead drug
-
The New Yorker
The C.E.O. of Anti-Woke, Inc.
Dec 20, 2022
-
Financial Times
Belgian biotech company Galapagos on the hunt for deals
-
The Washington Post
Weight-loss drugs like Ozempic, Mounjaro, Wegovy gain popularity, effectiveness
-
The Wall Street Journal
Flu, RSV and Covid Drive Demand for Children’s Pain Relievers and Fever Reducers
-
Fierce Pharma
Novartis prunes nearly 300 jobs in Garden State as corporate slimdown rolls on
Dec 19, 2022
-
Axios
Antibiotic, drug shortages highlight America’s supply chain problems — again
-
The New York Times
They Created a Drug for Susannah. What About Millions of Other Patients?
-
Fierce Pharma
After Novo’s Wegovy supply woes, rival Lilly sees shortages for Mounjaro, Trulicity
-
Reuters
Probe of Musk’s Neuralink to scrutinize long-criticized U.S animal welfare regulator
Dec 16, 2022
-
Politico
AbbVie exits the lobby
-
The New York Times
Can a Federally Funded ‘Netflix Model’ Fix the Broken Market for Antibiotics?
-
The Wall Street Journal
Siddhartha Mukherjee on How Cellular Medicine Could Fight Cancer, Diabetes
Dec 15, 2022
-
Stat News
Prisons say they can’t afford to cure everyone with hepatitis C. But some are figuring out a way
-
Fierce Biotech
45 days later, BioCryst abandons another drug, citing competition
-
The Pharma Letter
Novartis to divest five eye drugs to Harrow
-
The Wall Street Journal
Why You Might Be Having Trouble Buying Children’s Flu and Cold Medicine
Previous
